Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

  title={Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial},
  author={Kazutoshi Fukase and Mototsugu Kato and Shogo Kikuchi and Kazuhiko Inoue and Naomi Uemura and Shiro Okamoto and Shuichi Terao and Kenji Amagai and Shunji Hayashi and Masahiro Asaka},
  journal={The Lancet},

Figures and Tables from this paper

Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma.

  • Jeongmin ChoiS. G. Kim H. Jung
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2014

Effect of Helicobacter pylori Eradication on Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasm

Successful H. pylori eradication may reduce the occurrence of metachronous Gastric cancer after endoscopic resection in patients with early gastric cancer.

Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan

Surveillance endoscopy for MGC in patients who have undergone endoscopic resection for early gastric cancer should be performed even after successful H. pylori eradication, according to the incidence and risk factors.

Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial

It is suggested that H. pylori treatment may not prevent the development of MGC in background mucosa with IM, and microsatellite instability and mAb Das-1 reactivity showed significantly higher incidences in both the H.pylori-positive and -negative patients compared with the control group, thus suggesting that MSI and m Ab Das- 1 reactivity are associated with gastric neoplasia.

Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.

Patients with H. pylori following subtotal gastrectomy had a similar eradication rate to patients with an intact stomach and atrophy and intestinal metaplasia scores 12 mo after successful eradication were significantly lower in the eradication success group than in the eradicate failure group.

Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer

A systematic review and meta-analysis of 11 retrospective cohort studies and 3 randomized controlled trials indicated that the risk of metachronous gastric cancer was significantly lower in H. pylori eradication group than in noneradication group, and anti-H.

Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer

Assessment of the efficacy of Helicobacter pylori eradication after endoscopic resection of EGC for the prevention of metachronous gastric cancer found it to be effective.



Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.

  • N. UemuraT. Mukai G. Kajiyama
  • Medicine
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 1997
Results suggest that H. pylori eradication may improve neutrophil infiltration and intestinal metaplasia in the gastric mucosa and inhibit the development of new carcinomas.

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

It was found that the incidence of gastric cancer development at the population level was similar between participants receiving H pylori eradication treatment and those receiving placebo during a period of 7.5 years in a high-risk region of China.

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Among men between 55 and 65 years of age, the gastric cancer phenotype of H. pylori gastritis appears to be more common than expected and further follow up and continuing recruitment are necessary to fulfil the main aim of the study.

Helicobacter pylori eradication prevents the development of gastric cancer – results of a long-term retrospective study in Japan

This large-scale retrospective clinical study in Japan, which has a high mortality rate for gastric cancer, indicates that H. pylori eradication may prevent the development of Gastric cancer.

Long term follow up of patients treated for Helicobacter pylori infection

Preneoplastic gastric lesions regress at a rate equal to the square of time in patients rendered free of H pylori infection, and are suggested to be treated and cured of their H plyori infection.

The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease

H. pylori eradication may reduce their risk of developing gastric cancer in patients with gastric ulcer, and large-scale studies in additional populations of this important international public-health issue are warranted.

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

Univariate analysis showed that persistent H pylori infection, age >45 years, male subjects, alcohol use, and drinking water from a well were significantly associated with IM progression, which was more frequent in those with more extensive and more severe IM at baseline.

Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique

Based on “in depth” evidence presented at this workshop, the majority of the scientific task force favored a search-and-treat strategy in first-degree relatives of gastric cancer patients and an overwhelming majority felt that a more general screen- and-t treat strategy should be focused in the first instance on a population with a high incidence of H. pylori-associated diseases.

Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils

This study using the Mongolian gerbil model confirmed that eradication of H. pylori resulted in a significant decrease of polyp formation, inflammatory cell infiltration, and cellular proliferation in the gastric mucosa, and could diminish mucosal alterations linked to gastric carcinogenesis.

Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment.

Metachronous recurrence was detected significantly more frequently in patients whose synchronous multiple lesions were found during the initial treatment, and age affected the recurrence positively, however, gender and H. pylori infection had no significant relationship with metachronously recurrence.